Cargando…

Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection

Influenza pandemics and seasonal outbreaks have shown the potential of Influenza A virus (IAV) to enhance susceptibility to a secondary infection with the bacterial pathogen Streptococcus pneumoniae (Sp). The high morbidity and mortality rate revealed the poor efficacy of antiviral drugs and vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boianelli, Alessandro, Sharma-Chawla, Niharika, Bruder, Dunja, Hernandez-Vargas, Esteban A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906052/ https://www.ncbi.nlm.nih.gov/pubmed/27379214 http://dx.doi.org/10.3389/fcimb.2016.00060

Ejemplares similares

Hierarchical effects of pro-inflammatory cytokines on the post-influenza susceptibility to pneumococcal coinfection
por: Duvigneau, Stefanie, et al.
Publicado: (2016)

Modeling Influenza Virus Infection: A Roadmap for Influenza Research
por: Boianelli, Alessandro, et al.
Publicado: (2015)

Editorial: Multiscale computational approaches in infectious diseases
por: Hernandez-Vargas, Esteban A., et al.
Publicado: (2022)

In vivo Pharmacokinetic and Pharmacodynamic (PK/PD) Modeling and Establishment of the PK/PD Cutoff of Florfenicol Against Pasteurella multocida in Ducks
por: Xiao, Xia, et al.
Publicado: (2021)

In vivo Neutralization of Pro-inflammatory Cytokines During Secondary Streptococcus pneumoniae Infection Post Influenza A Virus Infection
por: Sharma-Chawla, Niharika, et al.
Publicado: (2019)

Megapneumonia Coinfection: pneumococcus, Mycoplasma pneumoniae, and Metapneumovirus
por: Hon, Kam Lun, et al.
Publicado: (2012)

The PK/PD Interactions of Doxycycline against Mycoplasma gallisepticum
por: Zhang, Nan, et al.
Publicado: (2016)

Impact of Oseltamivir Treatment on Influenza A and B Virus Dynamics in Human Volunteers
por: Hooker, Kyla L., et al.
Publicado: (2021)

Understanding the pneumococcus: transmission and evolution
por: Donkor, Eric S.
Publicado: (2013)

Editorial: Molecular Pathogenesis of Pneumococcus
por: Bai, Guangchun, et al.
Publicado: (2017)

Oseltamivir Treatment for Influenza During the Flu Season of 2018–2019: A Longitudinal Study
por: Li, Xiao-Guang, et al.
Publicado: (2022)

Pharmacologic effects of oseltamivir in immunocompromised adult patients as assessed by population PK/PD analysis and drug‐disease modelling for dosing regimen optimization
por: Sturm, Stefan, et al.
Publicado: (2020)

Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle
por: Ahmad, Ijaz, et al.
Publicado: (2015)

Correlation of PK/PD Indices with Resistance Selection for Cefquinome against Staphylococcus aureus in an In Vitro Model
por: Li, Yafei, et al.
Publicado: (2016)

The PK–PD Relationship and Resistance Development of Danofloxacin against Mycoplasma gallisepticum in An In Vivo Infection Model
por: Zhang, Nan, et al.
Publicado: (2017)

Oseltamivir/prednisone: Viral infections, bacterial coinfection and lack of efficacy: case report
Publicado: (2021)

Population PK and Semimechanistic PK/PD Modeling and Simulation of Relugolix Effects on Testosterone Suppression in Men with Prostate Cancer
por: Lee, Tien‐Yi, et al.
Publicado: (2022)

Oseltamivir in human avian influenza infection
por: Smith, James R.
Publicado: (2010)

Relationship between Cefquinome PK/PD Parameters and Emergence of Resistance of Staphylococcus aureus in Rabbit Tissue-Cage Infection Model
por: Xiong, Mingpeng, et al.
Publicado: (2016)

Molecular typing of the pneumococcus and its application in epidemiology in sub-Saharan Africa
por: Donkor, Eric S.
Publicado: (2013)

Global transcriptional responses of pneumococcus to human blood components and cerebrospinal fluid
por: Pettersen, Jens Sivkær, et al.
Publicado: (2022)

Topological data analysis to model the shape of immune responses during co-infections
por: Sasaki, Karin, et al.
Publicado: (2020)

Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
por: Chan, Renee W. Y., et al.
Publicado: (2022)

Coinfection with influenza virus and non-typeable Haemophilus influenzae aggregates inflammatory lung injury and alters gut microbiota in COPD mice
por: Wu, Xiao, et al.
Publicado: (2023)

Ceftobiprole: pharmacokinetics and PK/PD profile
por: Azanza Perea, José Ramón, et al.
Publicado: (2019)

In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis
por: Xiao, Xia, et al.
Publicado: (2015)

Editorial: Transmission, colonization, and molecular pathogenesis of pneumococcus
por: Vidal, Jorge E., et al.
Publicado: (2022)

A Study of the Pneumococcus and Streptococcus Groups in Their Relation to Influenza
por: Logan, W. R.
Publicado: (1921)

Efficacy comparison of oseltamivir alone and oseltamivir-antibiotic combination for early resolution of symptoms of severe influenza-A and influenza-B hospitalized patients
por: Ishaqui, Azfar A., et al.
Publicado: (2020)

The Pneumococcus
por: Whitney, Cynthia G.
Publicado: (2005)

Adherence to Oseltamivir Guidelines during Influenza Pandemic, the Netherlands
por: Fietjé, Esther H., et al.
Publicado: (2012)

Oseltamivir resistance in swine influenza: a brief discussion
por: Wiwanitkit, Viroj
Publicado: (2009)

Oseltamivir use amongst hospitalized patients infected with influenza
por: Herman, Michael, et al.
Publicado: (2014)

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
por: Hurt, Aeron C., et al.
Publicado: (2016)

Oseltamivir treatment of influenza A and B infections in infants
por: Mattila, Janna‐Maija, et al.
Publicado: (2021)

Evaluation of the Clinical Effectiveness of Oseltamivir for Influenza Treatment in Children
por: Qin, Jianru, et al.
Publicado: (2022)

Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets
por: Zhou, Yu-Feng, et al.
Publicado: (2020)

PK/PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida auris
por: Caballero, Unai, et al.
Publicado: (2023)

1518. Real-World Comparative Effectiveness of Baloxavir Marboxil versus Oseltamivir on Influenza-Related Complication and Resource Utilization
por: Neuberger, Eddie, et al.
Publicado: (2020)

Ebola virus infection modeling and identifiability problems
por: Nguyen, Van Kinh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r161vec689ufpsfp6ea2cfpvhf